Straits Times Index
3,173.93 +34.17 (+1.09%) S&P 500
3,951.57 +34.93 (+0.89%) Dow
32,244.58 +382.60 (+1.20%) Nasdaq
11,675.54 +45.02 (+0.39%) BTC-USD
28,006.63 -196.27 (-0.70%) CMC Crypto 200
607.82 +8.15 (+1.36%)
DexCom, Inc. (DXCM)
Pre-market:
| Previous close | 113.93 |
| Open | 113.95 |
| Bid | 113.00 x 800 |
| Ask | 120.00 x 2200 |
| Day's range | 114.01 - 117.43 |
| 52-week range | 66.89 - 134.76 |
| Volume | |
| Avg. volume | 2,514,206 |
| Market cap | 45.273B |
| Beta (5Y monthly) | 1.11 |
| PE ratio (TTM) | 22.52 |
| EPS (TTM) | 5.20 |
| Earnings date | 26 Apr 2023 - 01 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 129.95 |
- Business Wire
Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors
BURNABY, British Columbia, March 21, 2023--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced that its Dexcom G6 CGM System will be available to people of all ages with type 1 and type 2 diabetes in Manitoba who meet eligibility criteria.
- Zacks
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
- Yahoo Finance Video
Why Nick Jonas is raising awareness for diabetes at SXSW
Superstar recording artist Nick Jonas shares his experience with diabetes and why he's using his platform to improve access to diabetes care. Nick joins Yahoo Finance Senior Reporter Allie Garfinkle from SXSW in Austin, TX to discuss how health technology like continuous glucose monitoring (CGM) is easing the burden of managing diabetes. Watch as Nick opens up about his partnership with DexCom (DXCM), fatherhood, and his struggle with diabetes.
